SUMINAT 100MG contains Sumatriptan which belongs to a group of medicines called Antimigraine agents. It is used to treat migraine headache and helps to narrow the blood vessels. A migraine is a headache that causes severe throbbing pain or a pulsing sensation, usually on one side of the head. Migraine may be caused by the temporary widening of blood vessels in the head. This medicine reduces the widening of these blood vessels and helps to take away the headache and relieve other symptoms of a migraine attacks.
Sumatriptan is a selective serotonin (or 5-HT) receptors located on blood vessels in your brain which constricts cerebral blood vessels and used in the treatment of acute migraine attacks and also reduces the widening of blood vessels.
Before taking this SUMINAT 100MG inform your doctor if you any have heart problems, high blood pressure, circulation problems, kidney or liver problems. Pregnant and breastfeeding mothers should consult their doctor before using this medicine. It is not recommended for children and adolescents under 18 years of age. Do not drive or operate any machines, if you experience drowsiness. The common side effects are dizziness, weakness, pain, heaviness, hot flushes and drowsiness.
SUMINAT 100MG narrows the blood vessels in the head, stopping pain signals from being sent to the brain, and blocks the release of certain natural substances that cause pain, nausea, and other symptoms of migraine.
Always take SUMINAT 100MG exactly as your doctor has told you. Swallow this medicine with a glass of water and do not crush or chew.
Dizziness:
Get up and move around to feel awake and take small naps to edge off the sleepiness.
There is only limited information about the safety of SUMINAT 100MG for pregnant women, though up till now there is no evidence of any increased risk of birth defects. Your physician will weigh the benefits and potential risks before prescribing it to you.
SUMINAT 100MG may excrete in breast milk, hence it should be used with caution during breastfeeding. Consult your doctor before taking.
Do not drive or handle any machines if you feel drowsiness while taking this medicine.
Consumption of alcohol while taking this medicine may cause drowsiness.
There is limited information available on the use of SUMINAT 100MG in patients with kidney disease. Consult your doctor for advice.
SUMINAT 100MG is not recommended in patients with severe liver disease, and it should be used with caution in patients with liver disease. Consult your doctor for advice.
Tell your doctor if you are allergic (hypersensitive) to Sumatriptan.
SUMINAT 100MG is not recommended in patients with heart problem such as narrowing of the arteries or chest pains (angina) or had a heart attack. Consult your doctor for advice.
Inform your doctor before taking this medicine, if you have or had condition such as,
Tell your doctor if you are taking,
Drug | : | Sumatriptan |
Pharmacological Category | : | Antimigraine Agent |
Therapeutic Indication | : | Migraine Headache |
Dosage Forms | : | Tablet |
Store below 20-25°C and keep out of reach of children.
Does SUMINAT 100MG make you drowsy?
It may cause drowsiness while using this medicine in such case, do not drive or handle any machines.
Does SUMINAT 100MG cause liver damage?
No, it does not cause liver damage, but inform your doctor if you have any liver problem, before taking this medicine.
Is SUMINAT 100MG a controlled substance?
No, it is not a controlled substance and belongs to the drug class anti-migraine agents.
1. KD Tripathi MD. Autacoids and related drugs. Essentials of Medical Pharmacology 7th ed. New Delhi, May 2013. Page – 178.
2. Katzung BG. Histamine, Serotonin, & the Ergot Alkaloids. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. Page - 283.
3. Christopher J Derry, Sheena Derry, R Andrew Moore, and Cochrane Pain. Sumatriptan (oral route of administration) for acute migraine attacks in adults. Feb, 2012. [Accessed on July 20, 2021] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4167868/
4. Yudhveer Brar; Seyed Alireza Hosseini and Abdolreza Saadabadi. Sumatriptan. June 17, 2021. [Accessed on July 20, 2021] https://www.ncbi.nlm.nih.gov/books/NBK470206/
5. GlaxoSmithKline UK Ltd. Electronic Medicines Compendium (EMC); [Revised on July, 2020] [Accessed on July 20, 2021] https://www.medicines.org.uk/emc/files/pil.3294.pdf
The contents of this website are for informational purposes only and not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition. Do not disregard professional medical advice or delay in seeking it because of something you have read on this website.